AI and Biosimilars: Bridging Global Health Disparities and Enhancing Treatment Efficiency
AI and Biosimilars: Bridging Global Health Disparities and Enhancing Treatment Efficiency The intersection of artificial intelligence (AI) and biosimilars is creating new opportunities to address global health disparities and improve treatment outcomes. As the patents for many original biological drugs expire, biosimilars—medications that are highly similar to these original biologics—are emerging as cost-effective alternatives. The…